The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression.
about
Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.TNFAIP8 promotes prostate cancer cell survival by inducing autophagy.Tumor Necrosis Factor-α Induced Protein 8: Pathophysiology, Clinical Significance, and Regulatory Mechanism.Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine
P2860
The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@en
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@nl
type
label
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@en
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@nl
prefLabel
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@en
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@nl
P2093
P2860
P50
P356
P1476
The novel p53 target TNFAIP8 v ...... 3-dependent tumor suppression.
@en
P2093
Carl W Anderson
Daniel Menendez
Julie M Lowe
Kristin A Gabor
Sara A Grimm
P2860
P2888
P304
P356
10.1038/CDD.2016.130
P577
2016-11-11T00:00:00Z